Kyongbo Pharmaceutical Co Ltd Long-term Investment Intensity
Kyongbo Pharmaceutical Co Ltd long-term investment intensity. Kyongbo Pharmaceutical Co Ltd (214390) has a Long-term Investment Intensity of 2.7% as of December 2019. Long-term investments of ₩6.32 Billion represent 2.7% of total assets of ₩237.82 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Read 214390 total debt and obligations for a breakdown of total debt and financial obligations.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of Kyongbo Pharmaceutical Co Ltd (2014–2019)
Long-term investment intensity of Kyongbo Pharmaceutical Co Ltd from 2014 to 2019. This chart shows how Kyongbo Pharmaceutical Co Ltd's Long-term Investment Intensity has evolved across 6 annual periods from 2014 to 2019. As of December 2019, the intensity stands at 2.7%, reflecting long-term investments of ₩6.32 Billion against total assets of ₩237.82 Billion KRW.
Kyongbo Pharmaceutical Co Ltd Long-term Investment Intensity by Year (2014–2019)
Kyongbo Pharmaceutical Co Ltd long-term investment intensity by year from 2014 to 2019. The table below presents the year-by-year Long-term Investment Intensity for Kyongbo Pharmaceutical Co Ltd from 2014 to 2019, covering 6 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see 214390 total assets.
| Year | LT Investment Intensity | LT Investments (KRW) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 2.7% | ₩6.32 Billion | ₩237.82 Billion | ▲ +2.0 pp |
| 2018 | 0.6% | ₩1.41 Billion | ₩221.62 Billion | ▲ +0.0 pp |
| 2017 | 0.6% | ₩1.22 Billion | ₩204.87 Billion | ▼ -0.9 pp |
| 2016 | 1.4% | ₩2.95 Billion | ₩203.74 Billion | ▼ 0.0 pp |
| 2015 | 1.5% | ₩2.88 Billion | ₩195.49 Billion | ▲ +0.1 pp |
| 2014 | 1.3% | ₩2.26 Billion | ₩168.03 Billion | — |